Evidence check: IgG in the context of blood sugar

The question about IgG in the context of blood sugar requires careful interpretation. IgG antibodies are often used in commercial 'food sensitivity' tests (measuring IgG4 against foods). These tests are scientifically controversial: major allergy and immunology societies (e.g., EAACI, AAAAI) advise against them because IgG4 may indicate tolerance rather than intolerance. There is no robust evidence linking such IgG results to blood sugar fluctuations. In contrast, for autoimmune diabetes (type 1), IgG autoantibodies (e.g., against GAD65, IA-2) are clinically validated markers for diagnosis and risk assessment. However, these are not marketed as general 'blood sugar tests' and are used in specific medical contexts. For a consumer seeking to manage blood sugar, IgG food sensitivity panels lack evidence and are not recommended. The evidence is best described as marketing/unclear. Caution: a positive IgG result does not imply a clinically relevant reaction or an effect on blood glucose levels.